ArticleMolecular and cellular biochemistry2025

Empagliflozin and dapagliflozin decreased atrial monoamine oxidase expression and alleviated oxidative stress in overweight non-diabetic cardiac patients.

Loredana N Ionică et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.